Green Street Acquires IJGlobal, Leading Provider of Global Infrastructure Data, News and Events
5.9.2024 13:02:00 CEST | Business Wire | Press release
--Green Street Continues to Grow, Expanding Its Global Product Suite with Comprehensive and Granular Property-Level Data, News and Events in Infrastructure--
Green Street, the preeminent provider of commercial real estate intelligence and analytics in the U.S., Canada, and Europe, has acquired IJGlobal, part of the Delinian Group – leading provider of data, news, and events covering all aspects of the international infrastructure and energy finance industry. IJGlobal is Green Street’s fifth acquisition since 2020, and it follows the May 2024 acquisition of Locatus – a Netherlands based provider of independently sourced retail data and analytics in the Benelux region.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240905220824/en/
Green Street, the leading provider of Commercial Real Estate intelligence, acquires IJGlobal, a comprehensive infrastructure company that includes a data platform, global news, and industry leading events/awards. (Graphic: Business Wire)
“IJGlobal is committed to being the market’s most comprehensive source of infrastructure intelligence with a global presence across North America, South America, Asia, Africa, Europe, and Australia, and its great talent and reputation for providing top-quality objective insights make a strong fit for Green Street. IJGlobal’s deep coverage of infrastructure accelerates our commitment to expanding property-level data and analytics across sectors and geographies and dramatically strengthens our increasing coverage of the infrastructure sector on a global basis,” said Jeffry Stuek Jr., Green Street’s Chief Executive Officer. “We are excited to integrate these capabilities to provide our clients with industry leading insight.”
For more than 17 years, IJGlobal has been delivering the market’s most comprehensive infrastructure intelligence through a database of 55,000+ transactions, 41,000+ assets, and 3,400+ funds. Their team of experts publishes more than 40 stories a day to inform financial structure, policy, pricing, and key market players, helping customers manage risk and identify leads. They also track and celebrate key infrastructure and energy industry achievements through a multitude of annual Events and Awards that connect the market and accelerate deals. IJGlobal services a wide range of customer segments including financial advisers and lenders, legal advisers, Development Finance Institutions (DFIs), institutional investors, project sponsors, and infrastructure funds, among others.
Commenting on the sale, Andrew Pinder, Chief Executive Officer of Delinian, said, “In line with our continued strategy of ‘invest, grow and divest’ for each of our portfolio companies, we are delighted that Green Street represents such a great fit for IJGlobal. It offers the business an exciting opportunity to further expand its depth and reach of infrastructure insights, data and events, with access to resources and expertise within a broader property-level data and analytics ecosystem. We wish the IJGlobal team every success as they now transition to Green Street.”
For more information, visit the IJGlobal website or Green Street website.
About Green Street
Green Street is the preeminent provider of actionable commercial real estate research, news, data, analytics, and advisory services in the U.S., Canada, and Europe. For nearly 40 years, Green Street has delivered unparalleled intelligence and trusted data on the public and private real estate markets, helping investors, banks, lenders, and other industry participants optimize investment and strategic decisions. The firm delivers exclusive market information, conclusion-driven insights, and predictive analytics through a SaaS platform. To learn more, please visit https://www.greenstreet.com.
About IJGlobal
IJGlobal is a single source of data, intelligence and analysis covering all aspects of the international infrastructure and energy finance industry. IJGlobal delivers news, transaction and investor/fund data, and events for global infrastructure to market participants worldwide, and through a comprehensive database that encompasses all infrastructure transaction participants, exclusive daily news, live League Table rankings, and more. IJGlobal is headquartered in London and was founded in 1997. For more information, please visit https://hub.ijglobal.com/.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240905220824/en/
Contacts
Green Street Media
Green Street Media
media@greenstreet.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Murata Launches Ultra-Low Power AMR Sensors to Boost Battery Life in Healthcare and Wearables Devices27.4.2026 04:00:00 CEST | Press release
Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) has commenced mass production of its MRMS166R and MRMS168R anisotropic magnetoresistance (AMR) sensors for healthcare, wearable, and IoT devices. The MRMS166R is the first AMR sensor to combine an average current consumption of 20 nA with operation from a 1.2 V supply, enabling extended battery life in coin cell-powered systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260413296947/en/ [Murata Manufacturing Co., Ltd.] AMR sensor The devices are solid-state magnetic sensors used for switching applications. They detect the presence or absence of a magnetic field and generate an output signal that system logic uses to control functions such as transitions between active and sleep modes. This enables contactless switching without mechanical components, improving reliability, and supporting sealed, miniaturized designs. Automatic switching between active and
Sun Pharma signs Definitive Agreement to Acquire Organon27.4.2026 01:51:00 CEST | Press release
Organon stockholders to receive US$ 14.00 per share in cashThe deal values Organon at EV of US$ 11.75 billionCombined Business leverages complementary portfolios and global scale for sustained long‑term value creation Sun Pharmaceutical Industries Limited(Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Organon & Co. (NYSE: OGN) (“Organon”) today announced that they have entered into a definitive agreement under which Sun Pharma will acquire all outstanding shares of Organon for US$ 14.00 per share in an all‑cash transaction with an enterprise valuation of US$ 11.75 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260426881370/en/ Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, in 2021. Organon has a legacy of deep trust and strong brand equit
Andersen Global udvider sin tilstedeværelse i Afrika med lanceringen af medlemsfirma i Cameroun26.4.2026 20:56:00 CEST | Pressemeddelelse
Andersen Global træder ind på det camerounske marked, idet Phoenix Advisory bliver medlemsfirma og overgår til Andersen-brandet. Andersen in Cameroun er et specialiseret rådgivningsfirma, der leverer strategiske, erhvervsmæssige, finansielle og operationelle rådgivningsydelser til organisationer i forskellige vækstfaser. Firmaet er grundlagt af fagfolk med erfaring fra store internationale organisationer og kombinerer et stærkt lokalt og centralafrikansk funderet kendskab til forretningsmæssige, juridiske og skattemæssige regler med en skræddersyet tilgang, der har til formål at skabe konkrete og målbare resultater for klienterne. "Overgangen til Andersen-brandet afspejler vores engagement i at vokse sammen med vores kunder og imødekomme stadig mere komplekse behov," udtalte administrerende partner Albert Désiré Zang. "Vi tror på, at langsigtet succes skabes gennem tillid, kvalitet og vedvarende support. At blive et medlemsfirma styrker vores evne til at levere gennemtænkte, bæredygtig
PMCOrganometallix Announces Price Increase on All Products24.4.2026 22:55:00 CEST | Press release
Due to significant changes in market conditions, PMC Organometallix, Inc. announces that effective May 1, 2026, or as contracts permit, prices across all product lines globally will increase by 10-25%. This adjustment is driven by sustained cost pressures from key inputs including rising raw material costs and escalating freight and logistics expenses. While the company has been absorbing these increases, the current economic environment brought on by the geopolitical crisis of the Iran conflict requires this adjustment to continue providing the high-quality, consistent materials and supply reliability that customers expect. PMC Organometallix will implement these changes in a transparent, collaborative manner and values your partnership while navigating these economic challenges. Customers with questions or to discuss a specific situation should contact their account representative. About PMC Group PMC Group is a growth-oriented, diversified, global chemicals and plastics company deli
Frankfurt Higher Regional Court upholds BESREMi® arbitral award in favor of AOP Health24.4.2026 18:52:00 CEST | Press release
Today, the Higher Regional Court of Frankfurt upheld the February 20251 partial final ICC arbitral award in favor of AOP Orphan Pharmaceuticals GmbH (“AOP Health”) in its dispute with PharmaEssentia Corp. (“PharmaEssentia”). The ruling confirms the award which found the Taiwanese company to be liable for certain damages. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260424005227/en/ Portrait Dr. Rudolf Widmann, Founder AOP Health Credit: AOP Health/Daniel Ospelt Dr. Rudolf Widmann, one of the two founders of AOP Health, explains: “We very much welcome the Frankfurt Higher Regional Court’s decision that confirms our position. In the interest of our patients, we are dedicated to maintaining stable and sustainable access to BESREMi® and to responsibly navigating future challenges.” The Product in Dispute The conflict centers around BESREMi® (ropeginterferon alfa-2b), a product launched in 2019 and developed by AOP Health into
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom